A phase 2 efficacy and safety trial of ADU-S100 and pembrolizumab in adults with head and neck cancer Meeting Abstract
| Authors: | Cohen, E.; Ferris, R.; Adkins, D.; Zandberg, D.; Dudek, A.; Mathew, M.; Dunn, L.; Grilley-Olson, J.; Sukari, A.; Redman, R.; Bauman, J.; Kaczmar, J.; Nabell, L.; Saba, N.; Nadler, E.; Kim, Y.; Mehra, R.; Nair, N.; Honarmand, S.; Cutler, R. Jr; Burtness, B. |
| Abstract Title: | A phase 2 efficacy and safety trial of ADU-S100 and pembrolizumab in adults with head and neck cancer |
| Meeting Title: | 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019) |
| Keywords: | tumor; innate |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 7 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Nov 6-10 |
| Meeting Location: | National Harbor, MD |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2019-11-01 |
| Start Page: | 282 |
| Language: | English |
| ACCESSION: | WOS:000496473200816 |
| PROVIDER: | wos |
| PMCID: | PMC6833189 |
| PUBMED: | 31694725 |
| DOI: | 10.1186/s40425-019-0763-1 |
| Notes: | Meeting Abstract: P396 -- Source: Wos |
